{"title":"Puberty and its disorders","authors":"G. Butler, J. Kirk","doi":"10.1093/med/9780199232222.003.0018","DOIUrl":null,"url":null,"abstract":"\n\n\n • Puberty is defined as the acquisition of secondary sexual characteristics, with a view to reproductive capability.\n \n\n • Assessment of puberty can be done by Tanner stages or the puberty phases.\n \n\n • Timing of pubertal onset and sequence of changes is carefully controlled.\n \n\n • Premature sexual maturation:\n \n\n\n ◦ <8 years in girls; menarche <11 years\n \n\n ◦ <9 years in boys.\n \n\n • Central precocious puberty or gonadotropin-dependent precocious puberty:\n \n\n\n ◦ hormone secretion is similar to normal puberty\n \n\n ◦ may be idiopathic, genetic, or secondary to central nervous system/pituitary tumour or insult\n \n\n ◦ treatment is with gonadotropin-releasing hormone analogues.\n \n\n • Gonadotropin-independent precocious puberty (independent source of sex steroid, e.g. gonadal tumour):\n \n\n\n ◦ treatment should address the primary cause.\n \n\n • Late puberty:\n \n\n\n ◦ pubertal events within the later normal range.\n \n\n • Delayed onset of puberty:\n \n\n\n ◦ absence of secondary sexual characteristics:\n \n\n\n ■ >13 years in a girl\n \n\n ■ >14 years in a boy\n \n\n • Central causes (low follicle-stimulating hormone (FSH)/luteinizing hormone (LH)):\n \n\n\n ◦ chronic illness\n \n\n ◦ eating disorders\n \n\n ◦ physiological\n \n\n ◦ hypogonadotropic hypogonadism.\n \n\n • Peripheral causes (high FSH/LH):\n \n\n\n ◦ gonadal dysgenesis including chromosomal syndromes, e.g. Turner, Klinefelter\n \n\n ◦ gonadal damage including cancer treatments.\n \n\n • Treatment:\n \n\n\n ◦ low-dose sex hormone to induce growth and secondary sexual characteristics\n \n\n ◦ recombinant FSH/LH to induce fertility potential.","PeriodicalId":217485,"journal":{"name":"Paediatric Endocrinology and Diabetes","volume":"27 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatric Endocrinology and Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780199232222.003.0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
• Puberty is defined as the acquisition of secondary sexual characteristics, with a view to reproductive capability.
• Assessment of puberty can be done by Tanner stages or the puberty phases.
• Timing of pubertal onset and sequence of changes is carefully controlled.
• Premature sexual maturation:
◦ <8 years in girls; menarche <11 years
◦ <9 years in boys.
• Central precocious puberty or gonadotropin-dependent precocious puberty:
◦ hormone secretion is similar to normal puberty
◦ may be idiopathic, genetic, or secondary to central nervous system/pituitary tumour or insult
◦ treatment is with gonadotropin-releasing hormone analogues.
• Gonadotropin-independent precocious puberty (independent source of sex steroid, e.g. gonadal tumour):
◦ treatment should address the primary cause.
• Late puberty:
◦ pubertal events within the later normal range.
• Delayed onset of puberty:
◦ absence of secondary sexual characteristics:
■ >13 years in a girl
■ >14 years in a boy
• Central causes (low follicle-stimulating hormone (FSH)/luteinizing hormone (LH)):
◦ chronic illness
◦ eating disorders
◦ physiological
◦ hypogonadotropic hypogonadism.
• Peripheral causes (high FSH/LH):
◦ gonadal dysgenesis including chromosomal syndromes, e.g. Turner, Klinefelter
◦ gonadal damage including cancer treatments.
• Treatment:
◦ low-dose sex hormone to induce growth and secondary sexual characteristics
◦ recombinant FSH/LH to induce fertility potential.